Chemical & Engineering NewsProgentos Therapeutics raises $65 million for multiple sclerosis23 Maymore_vert
Business WireProgentos Therapeutics Closes $65 Million Series A Financing to Advance Treatments for Multiple Sclerosis and Other ...20 Maymore_vert